Kinase Inhibitors
Synthesis, Medicinal Effects, and Applications
1st Edition
Will be published approx. on 10. June 2026
Book
Hardback
106 pages
978-1-041-22115-9 (ISBN)
Description
Kinase inhibitors are the type of medications that target enzymes called kinases, which play a crucial role in signaling pathways involved in cell growth, proliferation, and survival. These inhibitors are used in the treatment of various cancers and other diseases. This book provides essential information in the design of new drug molecules for the development of kinase inhibitors. It includes the existing drugs and those under clinical trial that are involved in the development process.
Key Features
Highlights the synthesis, molecular mechanism, biochemical pathways, chemical and biological properties of kinase inhibitors.
Focuses on recent advances in these drugs used in the field of cancer and other diseases.
Researchers are provided with information on target identification, lead identification, and optimization during the drug development process.
Key Features
Highlights the synthesis, molecular mechanism, biochemical pathways, chemical and biological properties of kinase inhibitors.
Focuses on recent advances in these drugs used in the field of cancer and other diseases.
Researchers are provided with information on target identification, lead identification, and optimization during the drug development process.
More details
Series
Language
English
Place of publication
London
United Kingdom
Publishing group
Taylor & Francis Ltd
Target group
College/higher education
Professional and scholarly
Academic, Postgraduate, and Professional Reference
Illustrations
2 s/w Zeichnungen, 23 farbige Zeichnungen, 6 s/w Tabellen, 2 s/w Abbildungen, 30 farbige Abbildungen, 7 Farbfotos bzw. farbige Rasterbilder
6 Tables, black and white; 23 Line drawings, color; 2 Line drawings, black and white; 7 Halftones, color; 30 Illustrations, color; 2 Illustrations, black and white
Dimensions
Height: 216 mm
Width: 138 mm
ISBN-13
978-1-041-22115-9 (9781041221159)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions
Biswa Mohan Sahoo | Mohd Amin Mir | Bimal Krishna Banik
Kinase Inhibitors
Synthesis, Medicinal Effects, and Applications
E-Book
06/2026
1st Edition
CRC Press
€73.99
Available for download
Biswa Mohan Sahoo | Mohd Amin Mir | Bimal Krishna Banik
Kinase Inhibitors
Synthesis, Medicinal Effects, and Applications
E-Book
06/2026
1st Edition
CRC Press
€73.99
Available for download
Persons
Dr. Biswa Mohan Sahoo - Professor at the School of Pharmacy and Life Sciences, Jatni, Bhubaneswar, Odisha. Dr. Sahoo completed his M.Pharm from L.M College of Pharmacy, Gujrat University, Ahmedabad, and PhD from the School of Pharmaceutical Education and Research, Berhampur University, Odisha. He has also completed his postgraduate diploma in Pharmaceutical Regulatory Affairs from Hamdard University, New Delhi. He has published several research and review articles in peer-reviewed journals of national and international repute. He has authored several textbooks of international repute. He has published 8 patents in India and Australia. Dr.
Mohd Amin Mir - Assistant Research Professor at Prince Mohammad Bin Fahd University Al Khobar, Kingdom of Saudi Arabia. He was Assistant Professor from 2018 to 2020, at Uttaranchal University Department of Chemistry, Dehradun, (Uttarakhand). Dr. Amin Mir had published more than 95 research articles in various International and National journals. Dr. M. Amin Mir got Young Scientist Award, Chemical Sciences, Aufau International Award 2016, Best Researcher Award in "92nd International Research Awards on Engineering, Science & Technology" Pondicherry, India organized by IOSRD, Young Researcher in Pharmaceutical Chemistry under the Allied Health Sciences Discipline, Venus International Healthcare Awards - VIHA 2018
Dr. Bimal Krishna Banik - his career, spanning significant achievements in teaching, research, mentoring, and professional service. He completed his Ph. D. degree in Chemistry from the Indian Association for the Cultivation of Science, Calcutta. Then, he pursued postdoctoral research at Case Western Reserve University, Ohio and Stevens Institute of Technology, New Jersey. Dr. Banik was a Tenured Full Professor in Chemistry and First President's Endowed Professor in Science & Engineering at the University of Texas-Pan American. He was the Vice President of Research & Education Development at the Community Health Systems of Texas. Currently, Dr. Banik is a Full Professor at the Prince Mohammad Bin Fahd University, Kingdom of Saudi Arabia. Notably, he has been selected as a Fellow of Five International Scientific Societies and has been designated as a Distinguished Researcher/Distinguished Scientist.
Mohd Amin Mir - Assistant Research Professor at Prince Mohammad Bin Fahd University Al Khobar, Kingdom of Saudi Arabia. He was Assistant Professor from 2018 to 2020, at Uttaranchal University Department of Chemistry, Dehradun, (Uttarakhand). Dr. Amin Mir had published more than 95 research articles in various International and National journals. Dr. M. Amin Mir got Young Scientist Award, Chemical Sciences, Aufau International Award 2016, Best Researcher Award in "92nd International Research Awards on Engineering, Science & Technology" Pondicherry, India organized by IOSRD, Young Researcher in Pharmaceutical Chemistry under the Allied Health Sciences Discipline, Venus International Healthcare Awards - VIHA 2018
Dr. Bimal Krishna Banik - his career, spanning significant achievements in teaching, research, mentoring, and professional service. He completed his Ph. D. degree in Chemistry from the Indian Association for the Cultivation of Science, Calcutta. Then, he pursued postdoctoral research at Case Western Reserve University, Ohio and Stevens Institute of Technology, New Jersey. Dr. Banik was a Tenured Full Professor in Chemistry and First President's Endowed Professor in Science & Engineering at the University of Texas-Pan American. He was the Vice President of Research & Education Development at the Community Health Systems of Texas. Currently, Dr. Banik is a Full Professor at the Prince Mohammad Bin Fahd University, Kingdom of Saudi Arabia. Notably, he has been selected as a Fellow of Five International Scientific Societies and has been designated as a Distinguished Researcher/Distinguished Scientist.
Content
Kinase Inhibitors: Synthesis and Applications; Kinase Inhibitors in Cancer Therapy; In-silico Approaches for the Design of Kinase Inhibitors as Anticancer Agents; Kinase inhibitors in COVID-19; Kinase Inhibitors as Potential Antimicrobial Drugs. Index.